Paclitaxel: An inhibitor of angiogenesis in a vascularized breast cancer

被引：0
|
作者：
Lau, D [1 ]
机构：
[1] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [41] Weekly paclitaxel in metastatic breast cancer
    Chang, AY
    Rubins, J
    Asbury, R
    Boros, L
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 7 - 7
  • [42] 'Human breast cancer (MCF-7) cells are less sensitive to angiogenesis inhibitor tunicamycin
    Rodriguez, UT
    Colon, JC
    Sanchez, A
    Banerjee, DK
    FASEB JOURNAL, 2006, 20 (04): : A55 - A56
  • [43] Safety and efficacy of the multidrug resistance inhibitor Incel (Biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel
    Toppmeyer, D
    Seidman, AD
    Pollak, M
    Russell, C
    Tkaczuk, K
    Verma, S
    Overmoyer, B
    Garg, V
    Ette, E
    Harding, MW
    Demetri, GD
    CLINICAL CANCER RESEARCH, 2002, 8 (03) : 670 - 678
  • [44] Targeting Angiogenesis in Metastatic Breast Cancer
    Reddy, Sangeetha
    Raffin, Michael
    Kaklamani, Virginia
    ONCOLOGIST, 2012, 17 (08): : 1014 - 1026
  • [45] Angiogenesis as targeted breast cancer therapy
    Hayes, Daniel F.
    Miller, Kathy
    Sledge, George
    BREAST, 2007, 16 : S17 - S19
  • [46] Angiogenesis as a target for breast cancer therapy
    Rayson, D
    Vantyghem, SA
    Chambers, AF
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1999, 4 (04) : 415 - 423
  • [47] Angiogenesis as targeted breast cancer therapy
    Hayes, D. F.
    BREAST, 2007, 16 : S3 - S3
  • [48] Evaluation of angiogenesis in male breast cancer
    Frangou, EM
    Lawson, J
    Kanthan, R
    LABORATORY INVESTIGATION, 2003, 83 (01) : 28A - 29A
  • [49] The prognostic role of angiogenesis in breast cancer
    Leek, RD
    ANTICANCER RESEARCH, 2001, 21 (6B) : 4325 - 4331
  • [50] Targeting Angiogenesis in Advanced Breast Cancer
    Amelia B. Zelnak
    Ruth M. O’Regan
    BioDrugs, 2007, 21 : 209 - 214
12345